ANI Pharmaceuticals is building a leading Rare Disease company focused on Serving Patients, Improving Lives

RECENT NEWS

ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference

2026-05-27

READ MORE >

ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

2026-05-08

READ MORE >

NASDAQ - ANIP

$85.76

+ 0.71 (0.83%)

Pricing delayed by 20 minutes
Last updated 2026-07-07 12:33:00